American Trust Pacira Bio Sciences, Inc. Transaction History

American Trust

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 02, 2022	BUY	$51.24 - $58.89 $1,178 - $1,354	23 Added 0.48%	4,803 $255,000
Q2 2022 Oct 03, 2022	SELL	$51.49 - $81.64 $9,886 - $15,674	-192 Reduced 3.86%	4,780 $279,000
Q1 2022 Jun 08, 2022	BUY	$60.03 - $76.49 $64,772 - $82,532	1,079 Added 27.72%	4,972 $379,000
Q4 2021 Mar 17, 2022	BUY	$47.97 - $62.21 $186,747 - $242,183	3,893 New	3,893 $234,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of American Trust, based on Form 13F filings with the SEC.

Stay updated on American Trust with notifications on news.